| Long-term effects of psychedelic drugs: A systematic review JS Aday, CM Mitzkovitz, EK Bloesch, CC Davoli, AK Davis Neuroscience & Biobehavioral Reviews 113, 179-189, 2020 | 201 | 2020 |
| Adverse effects of psychedelics: From anecdotes and misinformation to systematic science AK Schlag, JS Aday, I Salam, JC Neill, DJ Nutt Journal of Psychopharmacology 36 (3), 258-272, 2022 | 168 | 2022 |
| Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects JS Aday, AK Davis, CM Mitzkovitz, EK Bloesch, CC Davoli ACS Pharmacology & Translational Science, 2021 | 127 | 2021 |
| Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials JS Aday, BD Heifets, SD Pratscher, E Bradley, R Rosen, J Woolley Psychopharmacology, 2022 | 118 | 2022 |
| 2019: A year of expansion in psychedelic research, industry, and deregulation JS Aday, EK Bloesch, CC Davoli Drug Science, Policy and Law 6, 2050324520974484, 2020 | 53 | 2020 |
| 2018: A watershed year for psychedelic science JS Aday, CC Davoli, EK Bloesch Drug Science, Policy and Law, 2019 | 37 | 2019 |
| Extended testing with the dot-probe task increases test–retest reliability and validity JS Aday, JM Carlson Cognitive Processing 20 (1), 65-72, 2019 | 35 | 2019 |
| Psychedelics and virtual reality: Parallels and applications JS Aday, CC Davoli, EK Bloesch Therapeutic Advances in Psychopharmacology, 2020 | 32 | 2020 |
| Neural mechanisms of emotions and affect JS Aday, W Rizer, J Carlson Emotions and Affect in Human Factors & Human-Computer Interaction 1, 27-87, 2017 | 27 | 2017 |
| Neurotensin NTS1 and NTS2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats F Steele, S Whitehouse, JS Aday, A Prus Brain Research, 2017 | 26 | 2017 |
| Can psychedelic drugs attenuate age-related changes in cognition and affect? JS Aday, EK Bloesch, CC Davoli Journal of Cognitive Enhancement, 1-9, 2019 | 23 | 2019 |
| Emerging Challenges for Psychedelic Therapy JS Aday, RL Carhart-Harris, JD Woolley JAMA Psychiatry, 2023 | 22 | 2023 |
| Temporal dynamics in attention bias: Effects of sex differences, task timing parameters, and stimulus valence JM Carlson, JS Aday, D Rubin Cognition and Emotion 33 (6), 1271-1276, 2019 | 21 | 2019 |
| Beyond LSD: A broader psychedelic zeitgeist during the early to mid-20th century JS Aday, EK Bloesch, CC Davoli Journal of Psychoactive Drugs, 1-8, 2019 | 21 | 2019 |
| Structural MRI-based measures of neuroplasticity in an extended amygdala network as a target for attention bias modification treatment outcome JS Aday, JM Carlson Medical Hypotheses 109, 6-16, 2017 | 20 | 2017 |
| Psychedelic drugs and perception: A narrative review of the first era of research JS Aday, JR Wood, EK Bloesch, CC Davoli Reviews in the Neurosciences, 2021 | 17 | 2021 |
| Personal psychedelic use is common among a sample of psychedelic therapists: Implications for research and practice JS Aday, Z Skiles, N Eaton, L Fredenburg, M Pleet, J Mantia, ER Bradley, ... Psychedelic Medicine, 2023 | 14 | 2023 |
| In the presence of conflicting gaze cues, fearful expression and eye-size guide attention JM Carlson, JS Aday Cognition and Emotion 32 (6), 1178-1188, 2018 | 14 | 2018 |
| Psychedelic commercialization: A wide-spanning overview of the emerging psychedelic industry JS Aday, BS Barnett, D Grossman, KS Murnane, CD Nichols, ... Psychedelic Medicine 1 (3), 150-165, 2023 | 12 | 2023 |
| Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA B Sessa, JS Aday, S O’Brien, HV Curran, F Measham, L Higbed, DJ Nutt Journal of Psychopharmacology 36 (3), 360-367, 2022 | 11 | 2022 |
Emily K. BloeschAssociate Professor of Psychology, Central Michigan University在 cmich.edu 的电子邮件经过验证
